CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium studyEunyoung Kang, Gordana Popović, Betty Leung et al.|Cancer|2022Cited by 46
MyD88 and TLR4 Expression in Epithelial Ovarian CancerMatthew S. Block, Georgia Chenevix‐Trench, Robert A. Vierkant et al.|Mayo Clinic Proceedings|2018Cited by 30
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium studyMartin Köbel, Jaime Lesnock, Eunyoung Kang et al.|The Journal of Pathology Clinical Research|2023Cited by 29
Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous CarcinomaFlurina A.M. Saner, Jennifer M. Koziak, Kazuaki Takahashi et al.|Clinical Cancer Research|2024Cited by 14
Concurrent RB1 loss and <i>BRCA</i> -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinomaFlurina A.M. Saner, Jennifer M. Koziak, Kazuaki Takahashi et al.|medRxiv|2023Cited by 5